Howard A. Rockman
Scientific Founder, Consultant and Member of Scientific Advisory BoardDr. Howard A. Rockman, M.D is Scientific Founder of Trevena Inc. and serves as its Consultant. Dr. Rockman serves as Chief of Cardiovascular Medicine of Duke University Medical Center. Dr. Rockman's research focuses on the molecular mechanisms of cardiac hypertrophy and heart failure, and the role of G-protein-coupled receptors in the development of disease. His recent work led to the discovery of a totally new signaling mechanism for these receptors, which is independent of G-protein activation, and opens the door for identification of a new breed of drug molecules that leverage the pathway. He serves as a Member of Scientific Advisory Board at Trevena, Inc. Dr. Rockman is the Edward S. Orgain Professor of Medicine at Duke University and Chief of Cardiology, with joint appointments in the Departments of Cell Biology and Molecular Genetics. He received his MD from McGill University in 1983, having completed medical residency at the Montreal General Hospital in 1987, and a Cardiology Fellowship at the University of California, San Diego in 1991.
Positions
- Company NameTrevena, Inc.Stock CodeTRVNPositionScientific Founder, Consultant and Member of Scientific Advisory BoardColleagues
- CLCarrie L. BourdowPresident, CEO & Chairman
- MAMark A. DemitrackSenior VP & Chief Medical Officer
- KSKatrine SuttonPrincipal Financial Officer & principal accounting officer
- RTRobert T. YoderSenior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- BYBarbara YanniIndependent Director
- RJRobert J. LefkowitzMember of Scientific Advisory Board
- JLJohn L. LaMattinaMember of the Scientific Advisory Board
